{"id":34487,"date":"2025-05-30T18:19:57","date_gmt":"2025-05-30T10:19:57","guid":{"rendered":"https:\/\/flcube.com\/?p=34487"},"modified":"2025-05-30T18:19:58","modified_gmt":"2025-05-30T10:19:58","slug":"danaher-partners-with-astrazeneca-to-advance-precision-medicine","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34487","title":{"rendered":"Danaher Partners with AstraZeneca to Advance Precision Medicine"},"content":{"rendered":"\n

US-based science and tech services giant Danaher Corporation (NYSE: DHR<\/a>) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN<\/a>) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.<\/p>\n\n\n\n

Leveraging Danaher Centers for Enabling Precision Medicine<\/strong>
The partnership will utilize Danaher\u2019s newly established Danaher Centers for Enabling Precision Medicine to streamline the end-to-end development of precision medicine solutions. The first product under this collaboration will incorporate technology from Danaher\u2019s subsidiary, Leica Biosystems. The initial focus will be on digital pathology and computational pathology solutions, as well as AI-powered diagnostic algorithms, aiming to improve diagnostic accuracy and patient outcomes.<\/p>\n\n\n\n

Driving Innovation in Diagnostic Solutions<\/strong>
By combining Danaher\u2019s expertise in scientific and technology services with AstraZeneca\u2019s strengths in pharmaceutical research and development, the partnership is poised to accelerate the adoption of precision medicine. This collaboration underscores the commitment of both companies to drive innovation in diagnostic solutions and enhance the delivery of personalized healthcare.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with…<\/p>\n","protected":false},"author":1,"featured_media":34488,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,130,535,871,1265],"class_list":["post-34487","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-astrazeneca","tag-danaher","tag-nasdaq-azn","tag-nyse-dhr"],"yoast_head":"\nDanaher Partners with AstraZeneca to Advance Precision Medicine - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34487\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Danaher Partners with AstraZeneca to Advance Precision Medicine\" \/>\n<meta property=\"og:description\" content=\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34487\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-30T10:19:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-30T10:19:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Danaher Partners with AstraZeneca to Advance Precision Medicine\",\"datePublished\":\"2025-05-30T10:19:57+00:00\",\"dateModified\":\"2025-05-30T10:19:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487\"},\"wordCount\":189,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/3001-1.webp\",\"keywords\":[\"AI\",\"AstraZeneca\",\"Danaher\",\"NASDAQ: AZN\",\"NYSE: DHR\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34487#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34487\",\"name\":\"Danaher Partners with AstraZeneca to Advance Precision Medicine - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/3001-1.webp\",\"datePublished\":\"2025-05-30T10:19:57+00:00\",\"dateModified\":\"2025-05-30T10:19:58+00:00\",\"description\":\"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34487\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/3001-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/3001-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Danaher Partners with AstraZeneca to Advance Precision Medicine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34487#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Danaher Partners with AstraZeneca to Advance Precision Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Danaher Partners with AstraZeneca to Advance Precision Medicine - Insight, China's Pharmaceutical Industry","description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34487","og_locale":"en_US","og_type":"article","og_title":"Danaher Partners with AstraZeneca to Advance Precision Medicine","og_description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.","og_url":"https:\/\/flcube.com\/?p=34487","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-30T10:19:57+00:00","article_modified_time":"2025-05-30T10:19:58+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34487#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34487"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Danaher Partners with AstraZeneca to Advance Precision Medicine","datePublished":"2025-05-30T10:19:57+00:00","dateModified":"2025-05-30T10:19:58+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34487"},"wordCount":189,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34487#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","keywords":["AI","AstraZeneca","Danaher","NASDAQ: AZN","NYSE: DHR"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34487#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34487","url":"https:\/\/flcube.com\/?p=34487","name":"Danaher Partners with AstraZeneca to Advance Precision Medicine - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34487#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34487#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","datePublished":"2025-05-30T10:19:57+00:00","dateModified":"2025-05-30T10:19:58+00:00","description":"US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with UK-based major AstraZeneca (AZ, NASDAQ: AZN) this week. The collaboration aims to enhance the ability of clinicians to accurately identify patients who are most likely to benefit from precision medicines, leveraging advanced technologies and solutions.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34487#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34487"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34487#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","width":1080,"height":608,"caption":"Danaher Partners with AstraZeneca to Advance Precision Medicine"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34487#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Danaher Partners with AstraZeneca to Advance Precision Medicine"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/3001-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34487"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34487\/revisions"}],"predecessor-version":[{"id":34489,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34487\/revisions\/34489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34488"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}